Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
N6 -Methyladenosine (m6 A) readers are dysregulated in renal cell carcinoma.
Mol Carcinog. 2021 May;60(5):354-362. doi: 10.1002/mc.23297. Epub 2021 Mar 23.
Mol Carcinog. 2021.
PMID: 33755994
Systematic expression analysis of m6A RNA methyltransferases in clear cell renal cell carcinoma.
Gundert L, Strick A, von Hagen F, Schmidt D, Klümper N, Tolkach Y, Toma M, Kristiansen G, Ritter M, Ellinger J.
Gundert L, et al.
BJUI Compass. 2021 May 3;2(6):402-411. doi: 10.1002/bco2.89. eCollection 2021 Nov.
BJUI Compass. 2021.
PMID: 35474700
Free PMC article.
Item in Clipboard
The N6 -methyladenosine (m6 A) erasers alkylation repair homologue 5 (ALKBH5) and fat mass and obesity-associated protein (FTO) are prognostic biomarkers in patients with clear cell renal carcinoma.
Strick A, von Hagen F, Gundert L, Klümper N, Tolkach Y, Schmidt D, Kristiansen G, Toma M, Ritter M, Ellinger J.
Strick A, et al. Among authors: gundert l.
BJU Int. 2020 Apr;125(4):617-624. doi: 10.1111/bju.15019. Epub 2020 Feb 17.
BJU Int. 2020.
PMID: 31985880
Item in Clipboard
Cite
Cite